The PE Ratio as of July 2024 (TTM) for Collegium Pharmaceutical, Inc. (COLL) is 14.37

According to Collegium Pharmaceutical, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 14.37. This represents a change of 35.06% compared to the average of 10.64 of the last 4 quarters.

Collegium Pharmaceutical, Inc. (COLL) Historical PE Ratio (quarterly & annually)

How has COLL PE Ratio performed in the past?

The mean historical PE Ratio of Collegium Pharmaceutical, Inc. over the last ten years is -10.41. The current 14.37 PE Ratio has changed -13900.71% with respect to the historical average. Over the past ten years (40 quarters), COLL's PE Ratio was at its highest in in the March 2020 quarter at 309.37. The PE Ratio was at its lowest in in the December 2019 quarter at -78.54.

Collegium Pharmaceutical, Inc. (COLL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Collegium Pharmaceutical, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Collegium Pharmaceutical, Inc. (COLL) Average PE Ratio

How has COLL PE Ratio performed in the past?

The current PE Ratio of Collegium Pharmaceutical, Inc. (COLL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Collegium Pharmaceutical, Inc. (COLL) PE Ratio vs. Peers

How is COLL’s PE Ratio compared to its peers?

Collegium Pharmaceutical, Inc.’s PE Ratio is less than Phibro Animal Health Corporation (58.03), less than ANI Pharmaceuticals, Inc. (33.98), greater than Procaps Group S.A. (5.95), less than Silver Spike Investment Corp. (14.84), greater than Amphastar Pharmaceuticals, Inc. (13.24), greater than Eagle Pharmaceuticals, Inc. (6.86), less than Alkermes plc (16.25), greater than Evolus, Inc. (-12.06), less than Prestige Consumer Healthcare Inc. (16.83), greater than Regencell Bioscience Holdings Limited (-33.94), greater than Pacira BioSciences, Inc. (13.22), greater than Intra-Cellular Therapies, Inc. (-70.24), less than Dr. Reddy's Laboratories Limited (20.32),

Build a custom stock screener for Collegium Pharmaceutical, Inc. (COLL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Collegium Pharmaceutical, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Collegium Pharmaceutical, Inc. (COLL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Collegium Pharmaceutical, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.